Fennec Pharmaceuticals Inc.
FENC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $172,498 | $298,160 | $252,240 | $114,426 |
| - Cash | $26,634 | $13,269 | $23,774 | $21,100 |
| + Debt | $19,340 | $30,954 | $24,899 | $4,988 |
| Enterprise Value | $165,204 | $315,845 | $253,365 | $98,314 |
| Revenue | $47,538 | $21,252 | $1,474 | $0 |
| % Growth | 123.7% | 1,341.6% | – | – |
| Gross Profit | $44,354 | $19,993 | $1,392 | $0 |
| % Margin | 93.3% | 94.1% | 94.4% | – |
| EBITDA | $4,798 | -$12,364 | -$21,692 | -$17,068 |
| % Margin | 10.1% | -58.2% | -1,471.5% | – |
| Net Income | -$436 | -$16,045 | -$22,774 | -$17,193 |
| % Margin | -0.9% | -75.5% | -1,544.9% | – |
| EPS Diluted | -0.016 | -0.6 | -0.95 | -0.67 |
| % Growth | 97.3% | 36.8% | -41.8% | – |
| Operating Cash Flow | $26,980 | -$17,143 | -$18,058 | -$14,222 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $26,980 | -$17,143 | -$18,058 | -$14,222 |